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The preceding paper (1)  records the initial attempts to isolate and 
purify the  soluble specific substance of the so  called E  strain  of a 
bacillus  of  the  Friedl~nder  group.  The  organism  was  originally 
isolated from a  spontaneous  epidemic of  pneumonia  among  stock 
guinea  pigs.  The  specifically  reactive  substance  which  has  been 
isolated appears  to  be  a  nitrogen-free  polysaccharide differing in 
many  respects  from  the  soluble  specific  substances  recovered 
from  the  three  fixed  types  of  Pneumococcus  (2).  However,  as 
ha  the  case  of  the  soluble  specific  substance  of  Pneumococcus 
Type II, only glucose  could readily be identified among the products of 
hydrolysis.  Moreover, the percentage of reducing sugars on hydrol- 
ysis is  almost the same in both substances, and  it  therefore seemed 
possible that both of them might in reality be identical and that the 
differences observed might be  due  to impurities,  In the preceding 
paper  procedures were  outlined which were  designed to  eliminate 
any  impurities present  in  the  Friedliinder polysaccharide,  but  the 
employment of these methods only resulted in recovery of the original 
substance practically  unaltered. 
A  comparison of  the  specific  substance  obtained  from  Type  II 
pneumococcus with that isolated from the E  strain of Friedliinder's 
bacillus shows that both polysaccharides rotate the plane of polarized 
light  to  the  right.  In  the  case  of  the  Friedl~inder  substance  the 
specific  rotation  is  +100  °,  while  the  Type  II  pneumococcus sub- 
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stance rotates  the plane of polarized light about  +74 ° .  Both sub- 
stances have acidic properties, but the  Friedl~nder specific substance 
has an acid equivalent  approximately  one-half  that of  the  Type  II 
polysaccharide.  Neither  of  the  two  products  gives  glucuronic 
acid tests  as  do  the specific substances  of Types I  and III pneumo- 
coccus.  Both polysaccharides fail to form precipitates when treated 
with  solutions  of  silver  nitrate,  copper  sulfate,  or  phosphotungstic 
acid;  both  are  precipitated  by  solutions  of  uranium  nitrate  and 
basic  lead  acetate.  Whereas  the  Type  II  pneumococcus  specific 
substance  gives  no  precipitate  with  either  barium  hydroxide  or 
neutral  lead  acetate,  the  Friedl~nder polysaccharide is  precipitated 
by both of these reagents. 
Because the two  specific  substances,  although  of widely different 
biological  origin, resemble each  other  so  closely  in  some  of  their 
chemical  properties,  the  Friedl~nder  polysaccharide  was  tested 
with Type II antipneumococcus serum, and a  precipitin reaction was 
found to  occur.  On  the  other hand,  there  was absence of  precipi- 
tation  when  this  substance  was  tested  with  antipneumococcus 
serum  of  the other  two  fixed  types.  It  then  became  necessary  to 
determine  as  far  as  possible  the  immunological  relationships  not 
only of  the  soluble  substances  of  the  E  strain  of  the  Friedl~nder 
bacillus and  of  Type  II pneumococcus, but of  the  microorganisms 
themselves.  The  present  paper  deals  with  the  facts  so  far ascer- 
tained in this study. 
EXPERIMENTAL. 
Microorganisms.--The  strain  of  Gram-negative  bacillus  from  which  the 
specific polysaccharide  was  derived  corresponds  in  its  cultural and  biological 
reactions to organisms of the encapsulatus group, and for laboratory purposes is 
referred to as the E strain.  Five other strains,  four of which, as will be shown 
later, are similar in their serological reactions to the original organism, have been 
used in this study.  It does not seem egsential at this time to enter into a detailed 
description  of  the individual  cultural characteristics  of each  strain;--they all 
possess in common the property of luxuriant growth on ordinary media with the 
elaboration of the abundant gummy, mucoid material characteristic of the group. 
Methods.--Rabbits  were immunized by the intravenous injection of stispensions 
of heat-killed organisms; small doses were administered every day for 6 days, and 
they were repeated after an interval of a week.  Three courses of injections were 
given, and the animals were bled 9 days following the last inoculation. O.  T.  AVERY,  3~.  I-IEIDELBERGER,  AND  W.  F.  GOEBEL  711 
The agglutination and precipitin tests were done as previously described for 
Pneumococcus.  The protective power of type sera against Friedl~nder's bacilli 
and pneumococci  was tested by injecting white mice intraperitoneally with varying 
doses of the virulent organisms and at the same time injecting a fixed quantity 
(0.2 cc.) of immune serum.  All animals were observed for at least  10 days fol- 
lowing injection, and  those  surviving this  period were  considered effectively 
protected. 
Agglutination.--Immune  rabbit  sera  were  prepared  against  two 
strains of Friedl~inder's bacillus.  One of these was the culture E  from 
which  the  specific polysaccharide  was isolated.  The  second  culture 
(Sc)  was isolated  from  the  blood of a  patient  suffering  from  pneu- 
monia.  The  study of the agglutinin  reactions of these two immune 
sera afforded an  opportunity,  first,  to  establish  the specific relation- 
ship of these two strains to each other and to other organisms of the 
group;  and  second,  to  confirm  the  immunological  relationships  be- 
tween Type II pneumococcus and the E  strain. 
It immediately becomes evident from Table I  that,  as others have 
previously  observed,  the  encapsulatus  group  does  not  consist  of 
organisms  which  are  immunologically  identical.  The  two  strains 
(E  and  Sc) chosen at random are antigenically distinct one from the 
other.  Observations by Julianelle  (3)  indicate,  however,  that  these 
two  strains  are  representatives  of  two  distinct  but not unusual im- 
munological  types,  since  of  forty  strains  of  Friedl~nder's  bacillus 
which  he  has  tested,  seventeen  were  found  to  be  immunologically 
identical  with either  Strain  E  or Strain  Sc.  It is not the purpose of 
this paper,  however, to deal with the serological relationships within 
the  Friedl~nder  group.  Of more immediate  interest  is  the fact,  as 
shown by the experiments  recorded in Table I,  that  the Friedl~nder 
Type E  strain reacts in antipneumococcus Serum II and that Type II 
pneumococcus  is  agglutinated  in  serum  produced  by immunization 
with  the  E  strain  of  Friedl~tnder's  bacillus.  An  immunological 
similarity,  therefore,  exists  between  these  two  biologically remote 
organisms,  and  this  relationship  is  reciprocal.  The experiment  also 
shows that  there is no immunological  relationship  between Pneumo- 
coccus  Type  II  and  the  other  strain  of  Friedl~nder's  bacillus 
tested  (Sc),  which,  although  a  typical  organism  of  the  encapsu- 
latus  group,  is  immunologically  distinct from Strain E. 712  SPECIFIC SUBSTANCE  OF FRIEDI~WDER~S  BACILLUS.  II 
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That other strains of Friedl~nder's bacilli, which are  immunologi- 
cally identical with Strain E, also react with antipneumococcus  serum 
Type II just as does the E  strain is shown in Tables II, nI, and IV, 
ill which are presented the results  of  agglutination  reactions of  six 
TABLE  n. 
Agglutination  of Friedldnder's Bacillus  and Pneumococcus Type II in Anti- 
Freidltinder Sera. 
Friedl~.nd- 
er's 
bacillus. 
E 
K 
H1 
H~ 
Fe 
Sc 
Pneumo- 
COCCUS 
Type 
II. 
1:5 
++++ 
++++ 
++++ 
++++ 
++++ 
+++ 
Anti-Friedlitnder Serum E.  Anti-Friedl~.nder  Serum So. 
1:1o 
++++ 
++++ 
++++ 
++++ 
++++ 
+++ 
1:20 
+++++++ 
++++ 
++++ 
++++ 
++ 
1:40 
+++ 
+++7+ 
4- 
1:80 
++ 
l:S  1:10 
++++  ++++ 
1:201:40 
+ 
1:80 
TABLE  III. 
Agglutination  o/Friedl~nder's  Bacillus in A ntipneumocoecus Serum Type II. 
Antipneumococcus  serum. 
FrledlRnder's 
bacillus. 
E 
K 
Ht 
H, 
F, 
Sc 
G, 
Normal horse 
SeIUUX. 
Type I.  Type n.  Type nI. 
1:1  1:10  1:1  1:10 
++++  ++++ 
++++  ++++ 
++++  ++++ 
++++  ++++ 
++++ ++++ 
1:1  1:10  1:1  1:1o 
N 
Salt 
solution. 
n 
M 
additional  strains.  When  the  strains  are  immunologically related 
to  Strain E  they react with antipneumococcus serum Type II; when 
they  are  immlmologically distinct  (Sc and Gg, Table III)  they fail 
to  react.  Moreover,  Table In  shows  that  the  agglutination  of 
Friedliinder's bacilli of the Strain E  group does not occur with anti- 714  SPECIFIC  SUBSTANCE  OF  FRIEDLAI~rDER'S  BACILLUS.  II 
pneumococcus sera of  Types  I and  III,  but  only in  that  of Type 
II.  This  fact  suggests that  the immunological relationship  between 
certain  strains  of the Friedl~nder bacillus and certain strains of Pneu- 
mococcus is dependent upon chemical similarities in the soluble specific 
substances of the organisms  concerned.  Table IV shows that  while 
Friedl~nder strains  of  the  E  type all react about equally in Type II 
antipneumococcus  serum, 'they  do  not  react  in  as  high  dilution  as 
does Pneumococcus Type II itself.  This  difference in  the  capacity 
of  the  two  kinds  of  bacteria  to  react  to  the  same  degree  in  the 
same immune serum shows a lack of complete immunological identity 
between  them,  a  fact  presumably  related  to  the  minor  chemical 
TABLE  IV. 
Agglutination of Friedlgnder's Bacillus by Antipneumococcus Serum II. 
Friedliinder's 
bacillus 
(strains). 
E 
K 
H, 
H2 
F6 
Sc. 
G9 
P~euInococcus 
Type II. 
1:5 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
Antipneumococcus  serum  Type  II. 
1:10 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
1:20 
+++ 
++++ 
+++ 
++++ 
++++ 
++++ 
1:40  1:80  1:160  1:320 
4-  --  --  -- 
4-  --  --  -- 
+++  -  _  _ 
4-  --  __  __ 
++++  ++++  ++  - 
Control. 
m 
differences which  appear  to  exist  between the  soluble specific sub- 
stances of the two organisms. 
Agglutinin Absorption.--Krumwiede and  his  associates  (4)  have 
recently published a  critical  and  analytical  review of the subject of 
agglutinin  absorption in which they point out the significance of the 
method  for  bacterial  identification.  It  will  be important  to  apply 
this method  with  great  exactness  to  the  present  problem,  but  at 
present we can only record the results so far obtained. 
The  results  of observations as given in Tables V  and VI indicate 
the  failure  of  reciprocal  absorption.  Unabsorbed  anti-Friedliinder 
serum  which  agglutinates  both  the  Strain  E  Friedl~Lnder  bacillus 
and Pneumococcus Type II to about the same  fiter,  loses its agglu- O.  T. AVERY~ 1~.  ITEIDELBERGER,  AND  W.  F.  GOEBEL  ~i5 
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tinins for both organisms when absorbed with the homologous strain 
of Friedliinder's bacillus.  On the other hand, absorption of the same 
serum with Pneumococcus Type II removes only the agglutinins for 
the absorbing organism and leaves the antibodies for the Friedl~tnder 
strain  only slightly reduced.  Similarly, absorption  of antipneumo- 
coccus serum Type II  with Pneumococcus of the homologous  type 
results in complete removal of agglutinins for both organisms, while 
absorption of the same serum  with the E strain of Friedl~nder's bacillus 
takes out the antibodies for this organism and only slightly reduces 
the agglutinating power of the serum for Type II pneumococcus. 
TABLE  VII. 
Predpitin  Reactions:  Anti-Friedlander  Serum  E  against  Carbohydrate  Fraaion 
Derived from Homologous Strain. 
Anfi-Friedl~der Serum E. 
0.2 ¢¢. 
Rabbit 84 .................. 
"  83 .................. 
"  82 .................. 
"  normal ............... 
Antipneumococcus serum Type 
II ....................... 
k  + 
k+++ 
k+++ 
+++ 
Carbohydrate  of Friedlgnder's bacillus (E). 
b  q 
b++-f 
k++q 
+++ 
+  + +++i 
+++ ++++i 
+++ 
+++ +++ 
++ 
+± 
+4- 
+++  -+ 
g 
o 
g 
:i: 
Precipitin Reactions.--Immunization  of rabbits with  Friedliinder's 
bacillus  (Strain  E)  engenders  antibodies  which  not  only  agglu- 
tinate organisms of the same type, but which precipitate the soluble 
specific  polysaccharide derived from  the  bacterial  cell.  As  in  the 
case of the specific  polysaccharide of Pneumococcus the  reactivity 
of  the  Frledl~nder substance  is  exhibited in  dilutions  as  great  as 
1:2  million.  This  fact is  evident in  Table vii, in  which immune 
rabbit sera in quantities of 0.2  cc.  are shown to react with minute 
amounts  of  the  carbohydrate derived from  the  homologous strain 
of Friedliinder's bacillus.  Just as antipneumococcus serum has been 
found to agglutinate Friedl~nder's bacilli  of the type represented by 
Strain E,  so  also  it  reacts in precipitin  tests  with  the  FriedlAnder 
specific substance in high dilution. O.  T.  AVERY,  M.  HEIDELBERGER~  AND  W.  F.  GOEBEL  717 
Cross-precipitin reactions between the pneumococcus and  Fried- 
l~tnder  polysaccharides  are  shown  in  Table  VIII.  The  soluble 
specific substances of both organisms are reciprocally reactive with 
the  antibacterial  serum  of  each in  dilutions  of  1:2  million.  The 
physical properties of the immune precipitate formed by the union 
of the pneumococcus carbohydrate with the anti-Friedltnder serum 
differ from those  of the opaque disk characteristic of  the  other re- 
actions in that the precipitate is less heavy, more transparent, and 
tends to form a  gelatinous film. 
The "specificity" of the reaction is illustrated in Table IX.  Here, 
four protein-free carbohydrates prepared from four different organ- 
TABLE  VIII. 
Cross-Predpitin Reactions. 
Carbohydrate of Friedl~,ndet's 
bacillus (E). 
Immm~e  sera. 
Anti-Friedlg.nder  E.  I 
Rabbit 84 .........  I++++ 
Anfipneumococcus  I 
Type II.  Horse 
91A  ..............  i++++ 
+++ 
+++  + 
Carbohydrate  of Pneumococcus  Type  II. 
++ 
+++ 
+  ± 
+  ± 
±  ++-+* 
++  -+ 
o  Q 
* Thin translucent film-like preci 3itate. 
isms are  tested in  cross-wed ~itin reactions with the corresponding 
antibacterial  serum  of  each  strain.  The  three polysaccharides de- 
rived from the  three fixed  types  of  Pneumococcus  show  only the 
specific type reactions in  antipneumococcus serum.  The  cross-pre- 
cipitation between the Type II pneumococcus specific substance and 
the  anti-Friedl~nder  serum,  and  the  reverse  reactions  are  again 
evident. 
Precipitin A bsorption.--Aliquot portions of diluted anti-Friedltnder 
serum were  separately absorbed  with  the  homologous culture  and 
with  Pneumococcus Type  II.  The  absorbed  antibacterial  serum 
was then tested for precipitins against dilutions of the carbohydrates 
derived  from  each  of  the  organisms.  The  results  are  given  in 
Table X. 718  SPECIFIC  SUBSTANCE  OF  FRIEDLANDER'S  BACILLUS.  II 
As in the case of agglutinin absorption, the anti-Friedl~tnder  serum 
(E) treated  with the  homologous bacilli  loses  its  precipitins  for both 
TABLE  IX. 
Precipitin Reactions of Soluble Specific Substances of Pneumococcus Types I, II, IH, 
and of Frledliinder's Bacillus (Strain E). 
Immune sera. 
Antipneurnococcus *Type I ............ 
"  "  II ........... 
"  "  III .......... 
Anti-Friedliinder~ E  .................. 
Carbohydrate fraction isolated from 
Pneomococcus. 
Type I.  Type II. 
++++ 
=  ++++ 
-  ]  ++ 
Type III. 
Friedliinder's 
bacillus (E). 
++++ 
++++ 
-  indicates no reaction; + +, delicate film-like  scale;  + + + +, heavy, com- 
pact, disk-like precipitate. 
* Immune horse serum. 
Immune rabbit serum. 
:~ Isolated, purified soluble specific substance in dilution of 1:50,000. 
TABLE  X. 
Prec~itin A bsorption. 
Carbohydrate fraction of 
Ffiedliinder's bacillus (E)  ........  1:10.000 
1:50,000 
1:100,000 
1:200,000 
Pneumococcus Type II ...........  1:10,000 
1:50,000 
1:100,000 
1:200,000 
Anti-FriedlSnder  Serum E. 
Unab- 
sorbed. 
+++ 
++++ 
++++ 
++++ 
+ 
++ 
++± 
+++ 
Absorbed  Absorbed 
with 
Frledlgnd-  with 
".r's bacillus  Pneumo- 
(E).  coccus  II. 
-  ++ 
-  +++ 
-  +++ 
-  ++++ 
Control. 
Normal 
rabbit 
serum. 
m 
m 
m 
the  Friedl~tnder  and  Pneumococcus  II  specific  substances,  whereas 
absorption  with  Type  II  pneumococci  removes  the  antibodies  for 
the  pneumococcus  polysaccharide,  but  leaves  those  for  the  Fried- O. T. AVERY, M. HEIDELBERGER~ AND W. F. GOEBEL  719 
l~nder  substance  only  slightly  diminished.  The  converse  of  this, 
in which antipneumococcus  serum is absorbed with each of the two 
cultures,  yields  similar  results,  Pneumococcus  Type  n  removing 
the  precipitins  for  both  specific  substances  and  the  Friedlitnder 
bacillus depleting the serum only of antibodies for its own substance. 
Protection.--The  facts  brought  out by  the  test-tube  reactions  of 
agglutination  and precipitation  find added confirmation in the more 
final  proof  of  reciprocal  protection  against  infection  in  the  animal 
body. 
The six strains of Friedl~nder's bacilli tested for virulence in mice have each 
caused a fatal infection in doses as small as 1 ten-millionth cc.  The protective 
power of immune sera against Friedl~nder's bacilli and plleumococci was tested 
by injecting white mice intraperitoneally with increasing doses of virulent organ- 
isms together with a fixed amount  of type serum.  Animals surviving 10 days 
were considered effectively protected.  All animals except the virulence controls 
received 0.2 cc. of immune serum. 
The  serum  of  a  rabbit  immunized  with  the  Friedl~nder  bacillus 
(Strain  E) was first tested for its power to protect mice against  infec- 
tion with virulent cultures of homologous and heterologous types of the 
Friedlitnder  bacillus. 
The  protocol  given  in  Table  XI  shows  that  0.2  cc.  of  the  anti- 
Friedl~nder  serum  Type  E  protected  animals  against  0.1  cc.  of  a 
virulent  culture  of  the  homologous  strMn  which  without  immune 
serum  caused death  of the mice  in  doses  of  one-millionth  cc.  On 
the other hand, the same serum afforded no protection in mice against 
a virulent heterologous Strain Sc, which, by the reaction of agglutina- 
tion,  was shown to be of another type. 
Since the E  strain of Friedl~nder's bacillus was found to be agglu- 
tinated  and its soluble specific substance to be precipitated by anti- 
pneumococcus serum Type n, it was of interest to determine whether 
protection  against  infection  with  a  biologically  different  organism 
was  possible  by  the  use  of  antipneumococcus  serum  Type  n. 
The  results  of  this  experiment  are  given  in  Table  xn. 
It  is  evident  from  Table XlI  that  mice  inoculated  with  0.2  cc. 
of  antipneumococcus  serum  Type  II  were  effectively  protected 
against  at  least  a  thousand  lethal  doses of the  virulent  E  strain  of 
Friedl~nder's bacillus.  As in  the  agglutinin  and precipitin  tests  the 720  SPECIFIC  SUBSTANCE  OF  leRYEDLANDER'S  BACILLUS.  II 
"specific"  nature  of  this  protective  reaction  is  shown  by  the  fact 
that  antipneumococcus  serum  Type I  afforded no  protection what- 
ever against infection (Table XIII). 
TABLE  XI. 
Protective  Action of Anti-Friedl~nder Serum (E) against Friedl~nder's Bacillus of 
Homologous a~ut Heterologous Types. 
Friedl'gnder's  bacillus. 
Anfi-Friedl~.nder 
Serum E.  Strain E.  Strain Sc. 
Amount of culture.  Result.  Amount of culture.  Result. 
CC° 
0.2 
0.2 
0.2 
0.2 
0 
0 
GG. 
0.1 
0.01 
0.001 
0.0001 
0.00001 
0.000001 
S. 
D. 40 
"  18 
gag. 
0.1 
0.01 
0.001 
0.0001 
0.00001 
0.000001 
D. 17 
"  18 
"  22 
"  22 
"  30 
"  23 
In this and the following tables  S.indicates  survived;  D.,death,  the numerals 
representing  the hours before death of the animal occurred. 
TABLE  XII, 
Protective Action of Antipneumococcus Serum Type II against Frledliinder's 
Bacillus (E). 
Friedl~.nder's  bacillus (E). 
C6. 
0.001 
0.0001 
0.00001 
0.000001 
0.0000001 
0.00001 
0.000001 
0.0000001 
Anfipneumococcus  Serum II. 
Amount.  Result. 
S. 
gg 
g' 
¢' 
~g 
co. 
0.2 
0.2 
0.2 
0.2 
0.2 
0 
0 
0 
Virulence controls. 
D. 51 
"  41 
"  44 
The  anfi-Friedl~nder  serum  prepared  by  immunization  with 
Strain  E  protected mice  against a  hundred  thousand lethal  doses of 
another  strain  (K),  which,  by  agglutination,  was  classified  as  be- 
longing to  the  same  type as  E.  Similarly  antipneumococcus serum O.  T.  AVERY,  M.  I  rEIDELBERGER,  AND  W.  F.  GOEBEL  721 
Type II afforded protection against the K strain just as it did against 
the E  strain; a fact which emphasizes again the immunological simi- 
larity of Friedl~inder's  bacillus of this type to Type II pneumococcus. 
The same protocol (Table XIII) shows that antipneumococcus serum 
Type I is wholly without protective action against this type of  Fried- 
TABLE  XIII. 
Protective Action  of Antipneumococcus  Serum  against Friedl~nder's Bacillus  (K). 
Friedl~inder's  bacillus 
(K) 
(Type E). 
0.1 
0.01 
0.001 
0.0001 
0.00001 
0.000001 
0.0000001 
Antipncumococcus  sera. 
Type  I.  0.2 cc. 
D.  18 
'"  18 
"  42 
"  18 
Type II.  0.2 cc. 
D. 42 
"  18 
S. 
Anti-Friedl£nder 
Serum E. 
Rabbit 84.  0.2 cc. 
D.  18 
S. 
~c 
tc 
t~ 
Virulence  controls. 
D. 21 
"  42 
"  19 
TABLE  XIV. 
Protective Action of Anti-Friedltinder Sera against Pneumococcus Type II. 
Anfi-Friedl~inder  serum, 
Pneumococcus 
Type II culture. 
c¢. 
0,2 
0,1 
0,01 
0.001 
0.0001 
0.00001 
0.000001 
0.0000001 
Virulence  controls.  Rabbit 84 D 
immunized  with 
Strain E.  0.2 cc. 
D, 36 
"  46 
"  46 
D. 46 
Rabbit  77  D 
immunized with 
Strain  Sc.  0.2  cc. 
D. 20 
"  46  "  20 
S.  "  20 
"  "  20 
"  "  26 
Anti13neumococcus 
serum  Type  n 
(Horse 91 A). 
0.2 cc. 
D. 42 
"  72 
S. 
Cg 
l~inder'sbacillus.  Moreover, Table XIV brings out the fact that protec- 
tive power against Type II pneumococcus infection is not possessed 
by the anti-Friedl[inder serum  produced  by Strain Sc, which both 
by agglutination and protection has been shown to belong to a type 
different from the effective Type E  strains. 722  SPECIFIC  SUBSTANCE  OF  ]~RIEDLANDER'S  BACILLUS.  II 
The further data presented in Tables XIV, XV, and XVI demon- 
strate the comparable protective power of antipneumococcus Type II 
and the anti-Friedliinder E  sera against infection with virulent Type 
TABLE  XV. 
Protective Action of Anti-Friedltinder Serum E  against Pneumococcus Type II. 
Pneumococcus 
Type II culture. 
c~. 
0.2 
0.1 
0.01 
0.001 
0. 00001 
0. 000001 
0.0000001 
Immune  sera. 
Anfi-Friedliinder  E  Antipneumoeoccus  II 
(Rabbit 84).  (Horse 91 A). 
Amount.  Result. 
0.2  D. 19 
0.2  S. 
0.2  " 
0.2  " 
0 
0 
0 
0.0000001 cc. of this culture =  450 colonies. 
Amount.  i  Result. 
0.2  D. 24 
0.2  "  48 
0.2  l  s. 
0.2  ]  " 
o  I 
0 
o  ! 
Virulence 
controls. 
D. 20 
"  20 
"  36 
TABLE  XVI. 
Comparative  Protective  Value  of Anti-Friedl~nder  and  Antipneumococcus  Serum 
against Pneumococcus Type II. 
Culture 
Pneumococcus 
Type II. 
c¢. 
0.2 
0.1 
0.01 
0.001 
0.0001 
0.00001 
0.000001 
0.0000001 
Immune  sera. 
Anti-Friedlttnder E  Antipneumococcus Type II 
(Rabbit 84).  (Horse 91  A). 
Amount.  Result. 
GG. 
0.2  S. 
0.2  " 
0.2  " 
0.2  " 
0.2  " 
0 
0 
0 
Amount.  Result. 
t:c. 
0.2  D. 44 
0.2  "  20 
0.2  "  44 
0.2  S. 
0.2  " 
0 
0 
0 
Virulence 
control. 
D. 26 
"  26 
"  44 
II  pneumococci.  Indeed  the  protective  potency  of  the  anti-Fried- 
lander serum  in pneumococcus  infection in  two of the  three  experi- 
ments is greater than,  and in  the third test,  equal  to  that exhibited O. T. AVERY, M. ITEIDELBERGER, AN]) W. F. GOEBEL  723 
by the Pneumococcus Type n  immune serum itself.  This is all the 
more  striking  since  in  the  former  case  immune rabbit  serum was 
used and in the latter the serum of a horse which had received more 
intensive immunization. 
The peculiar "specificity" of the reciprocal protection of anfisera 
of two kinds of bacteria so widely different in other biological charac- 
ters is  confirmatory of the immunological relationships of these or- 
ganisms  brought  out  by  the  cross-reactions  of  agglutination  and 
precipitation. 
DISCUSSION. 
While  comparison of  the  chemical properties of  the  two  soluble 
specific substances isolated from Pneumococcus Type II  and  Fried- 
l~tnder's bacillus (Strain E) reveals many points of resemblance, differ- 
ences are  also  found which are  too great  to be ignored.  That the 
substances in reality are identical and that the observed differences de- 
pend only upon impurities present may possibly  be  the  case, but 
the evidence so far obtained is entirely opposed to this assumption. 
It has been pointed out in the preceding paper (1) and in the papers 
dealing with  the  soluble  specific substances  of  pneumococci (2,  5) 
that widely differing methods of preparation,  calculated to  remove 
different kinds of accompanying inert matter, have yielded strictly 
comparable products.  This fact cannot be taken to indicate that the 
specific  substances  as  at  present  isolated  are  pure  chemical  com- 
pounds,  but  it  at  least  makes  reasonable  the  assumption  that  in 
each instance a  large proportion of the adventitious impurities has 
been eliminated.  The view that the specific substance isolated from 
Pneumococcus  Type  II and that recovered from the Friedllinder bacillus 
(Strain  E)  are not identical is  further supported by  certain of the 
serological findings, especially those which show that the absorption 
of agglutinins and precipitins is not reciprocal with the two organisms. 
If the fact that bacteria possess mutual absorptive capacity be ac- 
cepted as the criterion of their antigenic identity then the failure of 
the organisms in question to exhibit this property may be taken as 
further evidence of the lack of identity of the substances involved. 
However, granted a  chemical difference between the two specific 
substances,  it  becomes necessary  to  account  for  their  marked  ira- 724  SPECIFIC  SUBSTANCE  OF FRIEDLANDER'S  BACILLUS.  II 
munological similarity.  In the absence of further evidence as to the 
structural relations of the two substances, which can only be obtained 
when large amounts of material become available, it seems reasonable 
to assume that both contain in a portion of the complex molecule the 
same  or  a  closely  similar  configuration of  atoms.  This  essential 
similarity in molecular grouping would then determine the immuno- 
logical similarity of the two substances. 
In the case of Pneumococcus it has been shown that the polysac- 
charides by themselves are not antigenic, and it is believed that they 
become  antigenic  only  when  attached  to  some  other  substance, 
possibly the  protein of  the cell.  The  type-specific character of the 
antigenic response, however, is dependent almost entirely upon the 
nature of the polysaccharide and  not upon  the  substance to which 
it  is  attached.  Therefore,  since  the  specific  carbohydrate  sub- 
stance  of  the  Friedl~inder bacillus  (Strain  E)  and that of  Type II 
pneumococcus possess  in  common similar  chemical properties,  the 
antigenic response to each may also be similar even though the pro- 
teins  or  other  substances  with  which  they  are  combined be  quite 
dissimilar.  A discussion of the actual number of antigens and anti- 
bodies present must be deferred until more facts  are  available  (cf., 
however, in this connection, Landsteiner and van der Scheer (6)). 
A  striking and probably analogous example of common antigenic 
properties in substances of remote biological origin is furnished by the 
phenomenon  of  heterogenetic  specificity  originally  described  by 
Forssman  (7).  This investigator  showed  that  following the injec- 
tion of animal tissues of unrelated species common hemolytic anti- 
bodies for sheep corpuscles appear.  Landsteiner (8)  and  Taniguchi 
(9)  have shown that such heterogenetic antigens consist of two com- 
ponent parts,  one a  protein, the other probably a  lipoid  substance. 
Landsteiner and Simms (10)  have found that the lipoid constituent, 
although itself practically  devoid of  antigenic properties,  acquires 
true  antigenicity when  combined with protein, and that  the  anti- 
bodies thus induced react with the isolated lipoid fraction. 
The fact that two biologically unrelated organisms, Pneumococcus 
Type II and Friedliinder's bacillus (Strain E), possess certain similar 
serological  and  antigenic  properties  suggests  that  examples  of 
heterogenefic specificity likewise occur among bacteria.  In the case O. T. AVERY~ M. HEIDELBERGER,  AND W. F. GOEBEL  72~ 
of bacteria, however, the specific substance involved instead of being 
a  lipoid  appears  to  be  a  polysaccharide.  From the results reported 
in  the  present  papers  it  further appears  probable  that  when  the 
analogous specific polysaccharides of otherwise totally unrelated micro- 
organisms correspond sufficiently  in chemical constitution an immuno- 
logical  correspondence  also  results.  This  type  of  immunological 
correspondence in no way invalidates the systematic classification of 
bacteria based upon the more usual and general methods of species 
determination.  It is of greater immediate significance in connection 
with the study of problems dealing with bacteria as disease-producing 
agents than in the study of bacteria in their genetic relationships. 
SUMMARY. 
The chemical and immunological  properties  of the soluble  specific 
substances  of a  strain  of  Friedliinder's  bacillus  and  Pneumococcus 
Type II  are  described and correlated, and  the serological and  anti- 
genic similarity of these biologically unrelated organisms is discussed 
as an example of heterogenetic specificity among bacteria. 
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